- Home
- KD vs ELAN Comparison
KD vs ELAN Comparison
Compare KD & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KD
- ELAN
- Stock Information
- Founded
- KD 2020
- ELAN 1954
- Country
- KD United States
- ELAN United States
- Employees
- KD N/A
- ELAN N/A
- Industry
- KD EDP Services
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- KD Technology
- ELAN Health Care
- Exchange
- KD Nasdaq
- ELAN Nasdaq
- Market Cap
- KD 7.0B
- ELAN 7.2B
- IPO Year
- KD N/A
- ELAN 2018
- Fundamental
- Price
- KD $32.03
- ELAN $18.50
- Analyst Decision
- KD Strong Buy
- ELAN Buy
- Analyst Count
- KD 3
- ELAN 7
- Target Price
- KD $46.00
- ELAN $17.33
- AVG Volume (30 Days)
- KD 2.2M
- ELAN 10.3M
- Earning Date
- KD 11-05-2025
- ELAN 11-06-2025
- Dividend Yield
- KD N/A
- ELAN N/A
- EPS Growth
- KD N/A
- ELAN N/A
- EPS
- KD 1.23
- ELAN 0.88
- Revenue
- KD $15,061,000,000.00
- ELAN $4,484,000,000.00
- Revenue This Year
- KD $6.91
- ELAN $5.65
- Revenue Next Year
- KD $2.63
- ELAN $4.97
- P/E Ratio
- KD $25.85
- ELAN $21.30
- Revenue Growth
- KD N/A
- ELAN N/A
- 52 Week Low
- KD $22.26
- ELAN $8.02
- 52 Week High
- KD $44.20
- ELAN $19.08
- Technical
- Relative Strength Index (RSI)
- KD 46.60
- ELAN 59.35
- Support Level
- KD $31.15
- ELAN $18.23
- Resistance Level
- KD $33.90
- ELAN $19.08
- Average True Range (ATR)
- KD 0.82
- ELAN 0.53
- MACD
- KD 0.21
- ELAN -0.08
- Stochastic Oscillator
- KD 42.49
- ELAN 70.30
About KD Kyndryl Holdings Inc.
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.